Luye Pharma Group Ltd (LUP) — Cash Flow-to-Debt Ratio
Luye Pharma Group Ltd (LUP) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €344.86 Million could theoretically repay 0% of its total liabilities (€14.11 Billion) in one year. Check LUP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Luye Pharma Group Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Luye Pharma Group Ltd across 10 annual periods. Also explore LUP total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Luye Pharma Group Ltd (2016–2025)
Year-by-year debt coverage analysis for Luye Pharma Group Ltd. For market capitalisation and broader financial context, see Luye Pharma Group Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €1.78 Billion | €14.47 Billion | ▲ +918.2% |
| 2024 | 0.01x | €167.76 Million | €13.86 Billion | ▼ -90.9% |
| 2023 | 0.13x | €1.60 Billion | €11.96 Billion | ▲ +6.5% |
| 2022 | 0.13x | €1.65 Billion | €13.21 Billion | ▲ +824.7% |
| 2021 | 0.01x | €182.37 Million | €13.47 Billion | ▼ -83.6% |
| 2020 | 0.08x | €1.03 Billion | €12.53 Billion | ▼ -42.4% |
| 2019 | 0.14x | €1.42 Billion | €9.94 Billion | ▲ +31.4% |
| 2018 | 0.11x | €1.05 Billion | €9.60 Billion | ▼ -56.4% |
| 2017 | 0.25x | €964.10 Million | €3.86 Billion | ▲ +11.4% |
| 2016 | 0.22x | €592.03 Million | €2.64 Billion | — |